{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:27:17Z","timestamp":1785205637198,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:00:00Z","timestamp":1447113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-1021-6","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T05:42:29Z","timestamp":1447134149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of a high-dose target-controlled naloxone infusion on pain and hyperalgesia in patients following groin hernia repair: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Manuel Pedro","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Utke Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joergen","family":"Berg Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"issue":"9","key":"1021_CR1","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895\u2013926.","journal-title":"J Pain"},{"issue":"Suppl","key":"1021_CR2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","volume":"152","author":"CJ Woolf","year":"2011","unstructured":"Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(Suppl):S2\u201315.","journal-title":"Pain."},{"issue":"1\u20132","key":"1021_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3959(02)00053-2","volume":"99","author":"DD Price","year":"2002","unstructured":"Price DD, Staud R, Robinson ME, Mauderli AP, Cannon R, Vierck CJ. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain. 2002;99(1\u20132):49\u201359.","journal-title":"Pain"},{"issue":"1\u20132","key":"1021_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.pain.2005.08.019","volume":"118","author":"A Pielsticker","year":"2005","unstructured":"Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain. 2005;118(1\u20132):215\u201323.","journal-title":"Pain"},{"key":"1021_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/7854_2014_351","volume":"20","author":"BK Taylor","year":"2014","unstructured":"Taylor BK, Corder G. Endogenous analgesia, dependence, and latent pain sensitization. Curr Top Behav Neurosci. 2014;20:283\u2013325.","journal-title":"Curr Top Behav Neurosci."},{"issue":"1\u20133","key":"1021_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejphar.2011.01.059","volume":"657","author":"A Campillo","year":"2011","unstructured":"Campillo A, Cabanero D, Romero A, Garcia-Nogales P, Puig MM. Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice. Eur J Pharmacol. 2011;657(1\u20133):89\u201396.","journal-title":"Eur J Pharmacol"},{"issue":"6152","key":"1021_CR7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.1239403","volume":"341","author":"G Corder","year":"2013","unstructured":"Corder G, Doolen S, Donahue RR, Winter MK, Jutras BL, He Y, et al. Constitutive mu-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science. 2013;341(6152):1394\u20139.","journal-title":"Science"},{"issue":"3","key":"1021_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.pain.2013.09.002","volume":"155","author":"NK Singla","year":"2014","unstructured":"Singla NK, Desjardins PJ, Chang PD. A comparison of the clinical and experimental characteristics of four acute surgical pain models: dental extraction, bunionectomy, joint replacement, and soft tissue surgery. Pain. 2014;155(3):441\u201356.","journal-title":"Pain"},{"issue":"3","key":"1021_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2125.2009.03433.x","volume":"68","author":"C Staahl","year":"2009","unstructured":"Staahl C, Olesen AE, Andresen T, Arendt-Nielsen L, Drewes AM. Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review. Br J Clin Pharmacol. 2009;68(3):322\u201341.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1021_CR10","doi-asserted-by":"publisher","first-page":"e64608","DOI":"10.1371\/journal.pone.0064608","volume":"8","author":"MP Pereira","year":"2013","unstructured":"Pereira MP, Werner MU, Ringsted TK, Rowbotham MC, Taylor BK, Dahl JB. Does naloxone reinstate secondary hyperalgesia in humans after resolution of a burn injury? A placebo-controlled, double-blind, randomized, cross-over study. PLoS One. 2013;8(5):e64608.","journal-title":"PLoS One"},{"issue":"8","key":"1021_CR11","doi-asserted-by":"publisher","first-page":"e0134441","DOI":"10.1371\/journal.pone.0134441","volume":"10","author":"MP Pereira","year":"2015","unstructured":"Pereira MP, Donahue RR, Dahl JB, Werner M, Taylor BK, Werner MU. Endogenous opioid-masked latent pain sensitization: studies from mouse to human. PLoS One. 2015;10(8):e0134441.","journal-title":"PLoS One"},{"issue":"1","key":"1021_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pain.2007.11.018","volume":"138","author":"AL Naert","year":"2008","unstructured":"Naert AL, Kehlet H, Kupers R. Characterization of a novel model of tonic heat pain stimulation in healthy volunteers. Pain. 2008;138(1):163\u201371.","journal-title":"Pain"},{"issue":"2\u20133","key":"1021_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0304-3959(97)00160-7","volume":"74","author":"JL Pedersen","year":"1998","unstructured":"Pedersen JL, Kehlet H. Hyperalgesia in a human model of acute inflammatory pain: a methodological study. Pain. 1998;74(2\u20133):139\u201351.","journal-title":"Pain"},{"issue":"1","key":"1021_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2007.09.026","volume":"137","author":"EK Aasvang","year":"2008","unstructured":"Aasvang EK, Brandsborg B, Christensen B, Jensen TS, Kehlet H. Neurophysiological characterization of postherniotomy pain. Pain. 2008;137(1):173\u201381.","journal-title":"Pain"},{"issue":"5528","key":"1021_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1126\/science.1060952","volume":"293","author":"JK Zubieta","year":"2001","unstructured":"Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293(5528):311\u20135.","journal-title":"Science"},{"issue":"5706","key":"1021_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/278740a0","volume":"278","author":"JD Levine","year":"1979","unstructured":"Levine JD, Gordon NC, Fields HL. Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature. 1979;278(5706):740\u20131.","journal-title":"Nature"},{"issue":"5656","key":"1021_CR17","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/272826a0","volume":"272","author":"JD Levine","year":"1978","unstructured":"Levine JD, Gordon NC, Jones RT, Fields HL. The narcotic antagonist naloxone enhances clinical pain. Nature. 1978;272(5656):826\u20137.","journal-title":"Nature"},{"issue":"8255","key":"1021_CR18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/S0140-6736(81)91308-8","volume":"2","author":"MR Cohen","year":"1981","unstructured":"Cohen MR, Cohen RM, Pickar D, Weingartner H, Murphy DL, Bunney Jr WE. Behavioural effects after high dose naloxone administration to normal volunteers. Lancet. 1981;2(8255):1110.","journal-title":"Lancet"},{"issue":"4","key":"1021_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0143-4179(85)90010-1","volume":"6","author":"MR Cohen","year":"1985","unstructured":"Cohen MR, Cohen RM, Pickar D, Kreger D, McLellan C, Murphy DL. Hormonal effects of high dose naloxone in humans. Neuropeptides. 1985;6(4):373\u201380.","journal-title":"Neuropeptides"},{"issue":"2","key":"1021_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00006842-198503000-00004","volume":"47","author":"MR Cohen","year":"1985","unstructured":"Cohen MR, Cohen RM, Pickar D, Murphy DL. Naloxone reduces food intake in humans. Psychosom Med. 1985;47(2):132\u20138.","journal-title":"Psychosom Med"},{"issue":"23","key":"1021_CR21","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/0024-3205(82)90443-X","volume":"30","author":"MR Cohen","year":"1982","unstructured":"Cohen MR, Cohen RM, Pickar D, Murphy DL, Bunney Jr WE. Physiological effects of high dose naloxone administration to normal adults. Life Sci. 1982;30(23):2025\u201331.","journal-title":"Life Sci"},{"issue":"6","key":"1021_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/archpsyc.1983.04390010023003","volume":"40","author":"MR Cohen","year":"1983","unstructured":"Cohen MR, Cohen RM, Pickar D, Weingartner H, Murphy DL. High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses. Arch Gen Psychiatry. 1983;40(6):613\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"1021_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-7525-1-29","volume":"1","author":"RP Snaith","year":"2003","unstructured":"Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29.","journal-title":"Health Qual Life Outcomes."},{"issue":"6","key":"1021_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"1021_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","volume":"7","author":"MJL Sullivan","year":"1995","unstructured":"Sullivan MJL, Bishop SR, Kivik J. The pain catastrophizing scale: development and validation. Psych Assess. 1995;7(4):524.","journal-title":"Psych Assess"},{"issue":"5","key":"1021_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/BF01061030","volume":"9","author":"LB Sheiner","year":"1981","unstructured":"Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data. J Pharmacokinet Biopharm. 1981;9(5):635\u201351.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"2","key":"1021_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","volume":"35","author":"DR Wesson","year":"2003","unstructured":"Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35(2):253\u20139.","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"1021_CR28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/jcbfm.1989.59","volume":"9","author":"JJ Frost","year":"1989","unstructured":"Frost JJ, Douglass KH, Mayberg HS, Dannals RF, Links JM, Wilson AA, et al. Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography. J Cereb Blood Flow Metab. 1989;9(3):398\u2013409.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1021_CR29","unstructured":"Watson M, Lucas C, Hoy A, Back I. Principles of drug use in palliative medicine. In: Watson M, Lucas C, Hoy A, editors. Oxford handbook of palliative care. Oxford University Press; 2005. p. 35\u201379"},{"issue":"2","key":"1021_CR30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2466\/pms.99.2.679-687","volume":"99","author":"RR Edwards","year":"2004","unstructured":"Edwards RR, Ness TJ, Fillingim RB. Endogenous opioids, blood pressure, and diffuse noxious inhibitory controls: a preliminary study. Percept Mot Skills. 2004;99(2):679\u201387.","journal-title":"Percept Mot Skills"},{"issue":"5","key":"1021_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0006-3223(85)90030-7","volume":"20","author":"MR Cohen","year":"1985","unstructured":"Cohen MR, Pickar D, Cohen RM. High-dose naloxone administration in chronic schizophrenia. Biol Psychiatry. 1985;20(5):573\u20135.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"1021_CR32","first-page":"825","volume":"19","author":"MR Cohen","year":"1984","unstructured":"Cohen MR, Cohen RM, Pickar D, Sunderland T, Mueller 3rd EA, Murphy DL. High dose naloxone in depression. Biol Psychiatry. 1984;19(6):825\u201332.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1021_CR33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1161\/01.STR.17.3.404","volume":"17","author":"HP Adams Jr","year":"1986","unstructured":"Adams Jr HP, Olinger CP, Barsan WG, Butler MJ, Graff-Radford NR, Brott TG, et al. A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia. Stroke. 1986;17(3):404\u20139.","journal-title":"Stroke"},{"issue":"8","key":"1021_CR34","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/00003246-198908000-00009","volume":"17","author":"WG Barsan","year":"1989","unstructured":"Barsan WG, Olinger CP, Adams Jr HP, Brott TG, Eberle R, Biller J, et al. Use of high dose naloxone in acute stroke: possible side-effects. Crit Care Med. 1989;17(8):762\u20137.","journal-title":"Crit Care Med"},{"issue":"5","key":"1021_CR35","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1161\/01.STR.21.5.721","volume":"21","author":"CP Olinger","year":"1990","unstructured":"Olinger CP, Adams Jr HP, Brott TG, Biller J, Barsan WG, Toffol GJ, et al. High-dose intravenous naloxone for the treatment of acute ischemic stroke. Stroke. 1990;21(5):721\u20135.","journal-title":"Stroke"},{"issue":"6","key":"1021_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/BF02336951","volume":"12","author":"F Federico","year":"1991","unstructured":"Federico F, Lucivero V, Lamberti P, Fiore A, Conte C. A double blind randomized pilot trial of naloxone in the treatment of acute ischemic stroke. Ital J Neurol Sci. 1991;12(6):557\u201363.","journal-title":"Ital J Neurol Sci"},{"issue":"3","key":"1021_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2165\/00003088-197601030-00004","volume":"1","author":"BA Berkowitz","year":"1976","unstructured":"Berkowitz BA. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone. Clin Pharmacokinet. 1976;1(3):219\u201330.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"1021_CR38","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1213\/00000539-199403000-00021","volume":"78","author":"PS Glass","year":"1994","unstructured":"Glass PS, Jhaveri RM, Smith LR. Comparison of potency and duration of action of nalmefene and naloxone. Anesth Analg. 1994;78(3):536\u201341.","journal-title":"Anesth Analg"},{"issue":"6","key":"1021_CR39","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/0735-6757(94)90033-7","volume":"12","author":"JM Chamberlain","year":"1994","unstructured":"Chamberlain JM, Klein BL. A comprehensive review of naloxone for the emergency physician. Am J Emerg Med. 1994;12(6):650\u201360.","journal-title":"Am J Emerg Med"},{"issue":"5","key":"1021_CR40","doi-asserted-by":"publisher","first-page":"e62733","DOI":"10.1371\/journal.pone.0062733","volume":"8","author":"MU Werner","year":"2013","unstructured":"Werner MU, Petersen KL, Rowbotham MC, Dahl JB. Healthy volunteers can be phenotyped using cutaneous sensitization pain models. PLoS One. 2013;8(5):e62733.","journal-title":"PLoS One"},{"issue":"1\u20132","key":"1021_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0304-3959(98)00197-3","volume":"80","author":"JS Mogil","year":"1999","unstructured":"Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, et al. Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain. 1999;80(1\u20132):67\u201382.","journal-title":"Pain"},{"issue":"4","key":"1021_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/01677060802357388","volume":"22","author":"CD Bryant","year":"2008","unstructured":"Bryant CD, Zhang NN, Sokoloff G, Fanselow MS, Ennes HS, Palmer AA, et al. Behavioral differences among C57BL\/6 substrains: implications for transgenic and knockout studies. J Neurogenet. 2008;22(4):315\u201331.","journal-title":"J Neurogenet"},{"key":"1021_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/7854_2014_285","volume":"20","author":"MU Werner","year":"2014","unstructured":"Werner MU, Bischoff JM. Persistent postsurgical pain: evidence from breast cancer surgery, groin hernia repair, and lung cancer surgery. Curr Top Behav Neurosci. 2014;20:3\u201329.","journal-title":"Curr Top Behav Neurosci."}],"updated-by":[{"DOI":"10.1186\/s13063-016-1181-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T00:00:00Z","timestamp":1453248000000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-1021-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-1021-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-1021-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T20:26:26Z","timestamp":1475785586000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-1021-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,10]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-1021-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13063-016-1181-z","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,10]]},"article-number":"511"}}